eGFR 2575 ml/min/1.73 m 2 ), finerenone (1020 mg daily) significantly reduced the primary composite renal outcomedefined as kidney failure, sustained eGFR decline 40%, or renal deathby 18% compared to placebo (HR 0.82
This article breaks down what we know so far, explains the science behind the hype, and outlines what it means for people living with diabetes today
Qin, S., Zhang, K., Ding, X., Bai, S., Wang, J., Tian, G., Zeng, Q
A standard starting dose for Zepbound is 2.5 mg, Dr
The most commonly reported adverse reactions (occurring in more than 5% of patients) include joint pain, injection site reactions such as redness and itching, pain in the extremities, swelling, and muscle pain
With the pre-release scheduled for December 4, 2024 , and applications opening January 8, 2025 , now is the time to start planning your submission